March 24, 2026

Certara, Inc. (CERT) Stock Analysis: Exploring a 44.69% Potential Upside Amid Healthcare Innovation

Certara, Inc. (NASDAQ: CERT), a prominent player in the healthcare sector, is drawing investor attention with a promising 44.69% potential upside, as signaled by analyst ratings. With its niche focus..

Select Medical Holdings Corp (SEM) Stock Analysis: Evaluating Growth Potential with a Strategic Focus in Healthcare

Select Medical Holdings Corporation (NYSE: SEM) operates within the healthcare sector, specializing in medical care facilities across the United States. With a market capitalization of $2.02 billion, Select Medical has..

Celldex Therapeutics, Inc. (CLDX) Stock Analysis: Exploring a Potential 73% Upside in the Biotech Sector

Celldex Therapeutics, Inc. (NASDAQ: CLDX), a key player in the biotechnology sector, offers an intriguing investment narrative with its advanced pipeline of therapeutic antibodies aimed at addressing severe inflammatory, allergic,..

LivaNova PLC (LIVN) Stock Analysis: Evaluating a 26% Upside Potential in the Medical Device Sector

LivaNova PLC (NASDAQ: LIVN), a prominent player in the medical device industry, has been capturing investor attention with its robust growth prospects and strategic positioning in the healthcare sector. Headquartered..

PROCEPT BioRobotics Corporation (PRCT) Stock Analysis: Unveiling a 24% Potential Upside

PROCEPT BioRobotics Corporation (NASDAQ: PRCT), a pioneering name in the medical devices sector, is capturing investor attention with its innovative approach to urologic surgery. With a market capitalization of $1.47..

Kestra Medical Technologies (KMTS) Investor Outlook: A 46.58% Upside Potential Amidst Robust Revenue Growth

Kestra Medical Technologies, Ltd. (NYSE: KMTS) has been gaining attention in the healthcare sector, particularly among investors keen on the medical instruments and supplies industry. The company, with its focus..

Kiniksa Pharmaceuticals (KNSA) Stock Analysis: Strong Buy Ratings and 24.62% Potential Upside

Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA) is generating significant buzz in the healthcare sector with an enticing potential upside of 24.62%, according to recent analyst ratings. This UK-based biopharmaceutical company,..

Viking Therapeutics, Inc. (VKTX) Stock Analysis: Strong Buy Ratings Point to 184.86% Potential Upside

Viking Therapeutics, Inc. (VKTX), a clinical-stage biopharmaceutical company, is capturing the attention of investors with its promising drug pipeline and a staggering potential upside of 184.86%. Based in San Diego,..

Neogen Corporation (NEOG) Stock Analysis: Investor Outlook on Growth Potential Amid a 31.98% Upside

Neogen Corporation (NASDAQ: NEOG), a prominent player in the healthcare sector focusing on medical devices, has caught the attention of investors with its promising growth potential. Based in Lansing, Michigan,..

Premier, Inc. (PINC) Stock Analysis: Navigating Challenges with 2.97% Dividend Yield

Premier, Inc. (NASDAQ: PINC), a key player in the Health Information Services industry, stands at the intersection of healthcare innovation and financial stability. With a market capitalization of $2.34 billion,..

AdaptHealth Corp. (AHCO) Stock Analysis: A 24% Upside Amidst Healthcare Sector Shifts

AdaptHealth Corp. (NASDAQ: AHCO) is a company that has captured the attention of investors with its solid footing in the healthcare sector, specifically within the medical devices industry. As a..

Supernus Pharmaceuticals, Inc. (SUPN) Stock Analysis: Capitalizing on a 28% Potential Upside in the CNS Therapeutics Market

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a biopharmaceutical company dedicated to developing and commercializing treatments for central nervous system (CNS) diseases, presents an intriguing opportunity for investors. With a market capitalization..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: Navigating Potential 31.84% Upside Despite Revenue Challenges

PTC Therapeutics, Inc. (NASDAQ: PTCT), a prominent player in the biotechnology sector, stands out with a market capitalization of $5.5 billion. Headquartered in Warren, New Jersey, the company focuses on..

Agios Pharmaceuticals (AGIO) Stock Analysis: Biotech Growth Potential with a 41.85% Upside

Agios Pharmaceuticals, Inc. (AGIO), a prominent player in the biotechnology sector, is capturing the attention of investors with its promising growth potential. Headquartered in Cambridge, Massachusetts, Agios focuses on discovering..

Mirum Pharmaceuticals, Inc. (MIRM): Investor Outlook Reveals 39% Upside Potential Driven by Robust Revenue Growth

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM), a burgeoning player in the biotechnology space, is capturing the attention of investors with a compelling growth narrative. With a market capitalization of $5.4 billion,..

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: A 49.66% Potential Upside Beckons Investors

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) presents a compelling opportunity for investors, particularly those focused on the healthcare sector. Operating within the niche of Drug Manufacturers – Specialty & Generic, ANI..

Dynavax Technologies Corporation (DVAX) Stock Analysis: Steady Growth and Strategic Collaborations Fuel Investor Interest

Investors eyeing the healthcare sector may find Dynavax Technologies Corporation (NASDAQ: DVAX) an intriguing prospect. As a commercial-stage biopharmaceutical company with a focus on vaccine development, Dynavax has positioned itself..

National HealthCare Corporation (NHC) Stock Analysis: A Stable Player in the Medical Care Facilities Sector

National HealthCare Corporation (NYSE: NHC) is a notable entity within the healthcare sector, specifically in the medical care facilities industry. With a market capitalization of $2.51 billion, NHC operates a..

CONMED Corporation (CNMD) Stock Analysis: Unpacking a 20.67% Potential Upside in the Healthcare Sector

Investors eyeing opportunities in the healthcare sector may find CONMED Corporation (NASDAQ: CNMD) an intriguing prospect, especially given its potential upside of 20.67% according to recent analyst ratings. As a..

GRAIL, Inc. (GRAL) Stock Analysis: A Promising Upside in the Diagnostics & Research Sector

For investors seeking exposure in the healthcare sector, GRAIL, Inc. (NASDAQ: GRAL) presents an intriguing opportunity. With a market capitalization of $2.02 billion, GRAIL operates in the diagnostics and research..

Search

Funds

March 24, 2026

Search

Funds

March 24, 2026

FTSE 100

Funds